Context
Cortical gray matter (GM) loss is marked and progressive in childhood-onset schizophrenia (COS) during adolescence but becomes more circumscribed by early adulthood. Nonpsychotic siblings of COS probands could help evaluate whether the cortical GM abnormalities are familial/trait markers.
Objective
To map cortical development in nonpsychotic siblings of COS probands.
Design
Using an automated measurement and prospectively acquired anatomical brain magnetic resonance images, we mapped cortical GM thickness in healthy full siblings (n = 52, 113 scans; age 8 through 28 years) of patients with COS, contrasting them with age-, sex-, and scan interval–matched healthy controls (n = 52, 108 scans). The false-discovery rate procedure was used to control for type I errors due to multiple comparisons.
Setting
An ongoing COS study at the National Institute of Mental Health.
Participants
Fifty-two healthy full siblings of patients with COS, aged 8 through 28 years, and 52 healthy controls.
Main Outcome Measures
Longitudinal trajectories of cortical GM development in healthy siblings of patients with COS compared with matched healthy controls and exploratory measure of the relationship between developmental GM trajectories and the overall functioning as defined by the Global Assessment Scale (GAS) score.
Results
Younger, healthy siblings of patients with COS showed significant GM deficits in the left prefrontal and bilateral temporal cortices and smaller deficits in the right prefrontal and inferior parietal cortices compared with the controls. These cortical deficits in siblings disappeared by age 20 years and the process of deficit reduction correlated with overall functioning (GAS scores) at the last scan.
Conclusions
Prefrontal and temporal GM loss in COS appears to be a familial/trait marker. Amelioration of regional GM deficits in healthy siblings was associated with higher global functioning (GAS scores), suggesting a relationship between brain plasticity and functional outcome for these nonpsychotic, nonspectrum siblings.
Structural brain abnormalities are an established feature of schizophrenia, characterized by decreased total gray matter (GM) volume reduction in the cortex, hippocampus, and amygdala.1-4 Regional analyses of cortical GM, using either voxel-based morphometry or cortical thickness measures, show that most cortical GM deficits in schizophrenia are localized to the prefrontal and superior temporal cortices in adult patients with both first-episode and chronic disease.5-7 However, it remains unclear whether the GM abnormalities in schizophrenia are familial/trait markers or are secondary to some aspect of the illness itself.8-11 This can be addressed by studying populations at high risk for schizophrenia, typically close relatives, where most studies show smaller total and regional GM volumes12-15 and total white matter volumes16,17 and reduced GM volumes of the thalamus18 and/or hippocampal-amygdalar complex.15,19-22 However, as summarized in a recent meta-analysis,23 the results have been inconsistent across studies with some studies showing no GM reductions in these populations.24,25
Several studies indicate greater brain abnormalities seen by magnetic resonance imaging (MRI) in symptomatic, high-risk subjects who arguably manifest early signs of the disorder. There are fewer studies that focus selectively on nonpsychotic full siblings of patients with schizophrenia. These have mostly measured whole-lobe brain volumes, and the results have been inconsistent,23 finding no lobar GM deficits (mean [SD] sibling age, 35.8 [8] years)26 or showing GM reduction in the frontal and temporal lobes (mean [SD] sibling age, 40.3 [5] years).27 To our knowledge, the only study to examine finer cortical GM density mapping analysis examined discordant monozygotic and dizygotic twins (20 pairs, mean [SD] age, 49 [3.9] years) and suggested that there were genetically influenced GM deficits in polar and prefrontal cortical regions and illness/environmentally based deficits in the parietal cortex.14
Gray matter loss in schizophrenia appears progressive over time28-31 and is striking during adolescence for patients with childhood-onset schizophrenia (COS).32,33 This progressive loss in COS probands plateaus and becomes more circumscribed to the prefrontal and temporal cortices by early adulthood,34 at which time it mimics the pattern found in cortical thickness studies of adult schizophrenia. The longitudinal progression of GM loss in high-risk subjects remains largely unexplored. Although 1 study found progressive differences between high-risk subjects and controls at the 2-year follow-up,12 to our knowledge, there are no reported studies examining progressive developmental brain changes specifically in healthy siblings of patients with schizophrenia. Siblings of patients with COS are of particular interest in this regard because the progressive nature of the GM deficits in the younger COS probands is striking and their younger-aged siblings (8-28 years) are in a period during which major brain changes are taking place.35-38 Therefore, one would expect to find more striking, and perhaps earlier, developmental GM changes in siblings of patients with COS relative to those for siblings of patients with adult-onset disease, and if the cortical GM development is indeed under shared genetic control, one would expect siblings of patients with COS to show similar GM abnormalities and/or a similar pattern of cortical GM development over time.
As part of an ongoing COS study at the National Institute of Mental Health, all available full siblings of COS probands were scanned prospectively. Using serially acquired anatomical brain MRIs and an automated cortical thickness measurement, we report herein cortical GM development for 52 healthy siblings of patients with COS (113 scans) between ages 8 and 28 years, with no diagnosable psychotic or schizophrenia spectrum disorder or drug treatment, comparing them with 52 matched healthy controls (108 scans) matched for age, sex, and scan interval. We hypothesized that the “healthy” (defined as nonpsychotic and nonschizophrenia spectrum) siblings of patients with COS would share some pattern of GM loss with their probands and that this GM loss would be more striking than that seen in siblings of adult-onset cases. On an exploratory basis, we examined the developmental trajectories of these abnormalities in relation to their overall functioning as defined by their Global Assessment Scale (GAS) score.
Since 1991, through national recruitment and prescreening of more than 2000 submitted case records and in-person screening of more than 230 subjects, 92 patients to date have met unmodified DSM-III-R/DSM-IV criteria for schizophrenia with onset of psychosis before their 13th birthday. Patients with a history of significant medical problems, substance abuse, or an IQ lower than 70 prior to the onset of psychotic symptoms were excluded. Further details of patient selection, including those for the COS sample used for comparison in this study, are described elsewhere.39,40
Siblings of Patients With COS
All available biological full siblings of patients with COS participated in the study and were scanned prospectively every 2 years along with their probands. Siblings were interviewed using structured psychiatric interviews for Axis I (using either the Schedule for Affective Disorders and Schizophrenia [SADS]41 or the Schedule for Affective Disorders and Schizophrenia for School-Age Children [K-SADS]42) and Axis II (using the Structured Interview for the DSM-III Personality Disorders [SIDP]43) diagnoses, and their GAS scores were estimated by a child psychiatrist.44 Siblings were considered “healthy” if they were free of any psychotic or schizophrenia spectrum disorder (which included schizophrenia, schizoaffective disorder on Axis I, or paranoid, schizotypal, schizoid, or avoidant personality disorders on Axis II).45 Additionally, symptom counts for all Axis II disorders were calculated both for individual disorders and also cumulatively for schizophrenia spectrum diagnoses. Of a total of 83 full siblings, 69 could be considered healthy, of which 52 had at least 1 MRI available for cortical thickness estimation. The remaining 17 were either not available for MRI (n = 6), refused MRI (n = 4), had metal objects in their body (n = 3), or their scans could not pass the automated processing (n = 4). To correlate GM cortical thickness with functional outcome, GAS scores were obtained on healthy siblings at the end of the study (mean [SD] age, 19.2 [7.6], at last interview) by a child psychiatrist.
A group of 52 unrelated healthy controls was selected from a sample of community volunteers recruited as part of a prospective study of normal brain development and matched for sex, age, number of repeated scans, and scan interval. Controls were free of lifetime medical or psychiatric disorders as determined by clinical examination and standardized interview. Psychiatric illness in a first-degree relative was also exclusionary.38
The research protocol was approved by the National Institute of Mental Health institutional review board. Written informed consent was obtained from parents and controls and patients older than 18 years, and written informed assent was obtained from minors.
Mri acquisition and image analysis
Briefly, T1-weighted images with contiguous 1.5-mm slices in the axial plane were obtained using a 3-dimensional spoiled gradient recalled echo sequence in the steady state. Imaging parameters were echo time of 5 milliseconds, repetition time of 24 milliseconds, flip angle of 45°, acquisition matrix of 256 × 192, number of excitations equaled 1, and a 24-cm field of view. Head placement was standardized as previously described.46 Magnetic resonance images were registered into standardized space using a linear transformation and corrected for nonuniformity artifacts.47 Registered and corrected volumes were segmented with an advanced neural net classifier48 and GM and white matter surfaces were fitted with a surface deformation algorithm,49,50 which first determines the white matter surface, then expands outward to find the GM–cerebrospinal fluid intersection. As a result, GM and white matter surfaces with more than 80 000 polygons each are fit and nonlinearly aligned using a template surface registration so each vertex of the white matter surface corresponds to a GM surface counterpart, thereby generating linked polygons on the GM and white matter surfaces.51 Cortical thickness measurements, defined as the distance between linked vertices of the GM and white matter boundaries using a 30-mm surface-based blurring kernel (which has been shown to maximize statistical power), have been previously validated and were calculated in native space at 40 962 cortical points.52
Statistical analyses examined the data from only the healthy siblings and their matched control groups. The COS data have been published elsewhere34 and are shown (Figure 1B) only for visual comparison of GM changes between COS probands and healthy siblings of patients with COS.
Differences in sibling/control group demographics were tested using t tests or Mann-Whitney U tests (if assumptions were violated) for continuous variables, χ2 tests of independence for categorical variables, and the Fisher exact test for categorical variables if there was an expected cell count less than 5. Mixed-model regression was used to examine cortical thickness development and was chosen over traditional methods (ie, repeated-measures analysis of variance, fixed-effects regression models) because it permits the inclusion of cross-sectional as well as longitudinal data, thus allowing multiple measurements per person, missing data, and irregular intervals between measurements, thereby increasing statistical power.53 There were 14 siblings and 14 controls with only 1 scan and 38 siblings and 38 controls with more than 1 scan. Thirteen of 35 families contributed more than 1 sibling. Controls were unrelated. Because multiple siblings per family and multiple scans per person over time were included in the analyses, 2 random intercepts were included for all analyses: one intercept to model within-family dependence and one intercept to model person within-family dependence. The regression model was fit at every cortical point regressing cortical thickness against group, age (centered at the sample average age), and group × age. A straight-line fit was deemed adequate to model cortical thickness development because the combined contribution of quadratic age terms for both groups was not a significant contributor to the explanatory power of the model across the cortical surface after using a false-discovery rate correction. Cortical thickness was measured in native space and the siblings and controls did not differ in either total cerebral volume (P = .30) or mean cortical thickness (P = .75), based on mixed-effect regression contrasts of group intercepts at the average age. As such, we did not correct for interindividual differences in brain size.
To explore the relationship between cortical thickness and sibling functioning, cortical thickness was regressed on GAS score using GAS scores as a continuous measure andcontrolling for the effects of age, using all scans from siblings for whom we had obtained GAS scores (n = 51) using the model:
corticalthickness = intercept + B1 (GAS score) + B2 (age),
where B1 is a fixed effect and presents the change in thickness associated with a 1-point change in GAS score (controlling for the effects of age). We also ran a model that interacted age and GAS score; however, for unknown reasons, this resulted in problems with model convergence for numerous vertices, and there were no significant interaction effects after we applied a false-discovery procedure. Scans with a mean cortical thickness value less than 2.0 (a cutoff chosen to exclude unrealistic values) were considered outliers and deleted from the sample. This resulted in 1 control scan being omitted because the mean cortical thickness (averaged across all 40 962 points) was less than 2.0 (an unrealistic value). One other control scan was of insufficient quality to yield cortical thickness measurements and could not be included.
We pooled P values for all terms excluding the intercept (age, diagnosis, and age × diagnosis) because none of the terms were considered confounds but rather effects of interest. We also chose this approach in an attempt to be more conservative by keeping the ratio of falsely rejected hypotheses to all rejected hypotheses at 0.05 (the q we chose for our false-discovery rate procedure) for each regression analysis rather than for 1 term in the model.54
These analyses entailed the same model as in the “Statistical Analysis” subsection but recentered age at approximate 3-year intervals within the middle 80% of the age range. This approach permits interpretation of the intercept and group differences at the centered age (instead of at age zero). It also permits maximal use of the entire data set without separating participants into age groups and thereby diminishing statistical power. Thus, the differences that are visually represented at different ages are essentially snapshots of the differences between the 2 groups' regression lines at the specified age, where all scans are informing all pictures in Figure 1.
Sample demographics are shown in the Table. As seen in the Table, the samples are well matched on all the variables with the exception of socioeconomic status, which was lower for siblings of patients with COS than for the unrelated healthy controls (P = .03)
There were no significant mean cortical thickness differences between the healthy siblings and their matched controls. When cortical GM development was visualized between ages 8 and 28 years, healthy siblings showed a more restricted pattern of GM loss compared with their probands, which was still localized to the prefrontal and superior temporal cortices (Figure 1). The GM deficits appeared at age 8 years, mainly in the prefrontal (superior and middle frontal gyri) and temporal cortices (superior and middle temporal gyri), most prominently on the left side, but gradually lessened through adolescence and disappeared by age 20 years (Figure 1). There was no significant parietal GM loss except for a small region in the inferior parietal cortices (Figure 1, left side of the brain, and Figure 2C), which was not apparent by age 17 years (Figure 2C).
Analyses of GM trajectories of COS probands (compared with matched controls) are provided in Figure 1B. These are published elsewhere34 and shown here only for visual comparison of the patterns.
Visual comparison of the GM deficit patterns of patients with COS and siblings of patients with COS over time shows a broad pattern of early deficits, which somewhat improve with age and localize to the prefrontal and temporal cortices in patients with COS but disappear in healthy siblings by age 20 years (Figure 2). The GM developmental trajectory appears to be shifted to earlier ages (shift to left) in healthy siblings of patients with COS possibly because the controls have a steeper slope of GM loss than in the siblings in these areas (Figure 2).
When cortical thickness was regressed with GAS scores of healthy siblings, significant positive relationships between GAS score and thickness were noted. Cortical thickness increased with higher GAS scores in the bilateral frontal and temporal cortices (Figure 3). Additionally, the GAS scores also showed positive correlation with the mean cortical thickness at initial scan in healthy siblings.
This is a prospective study mapping longitudinal GM development in healthy siblings of patients with COS in spatiotemporal detail. This sample was of particular interest because the age range (8-28 years) encompassed periods of active brain development and organization. Beginning at an early age, healthy siblings of patients with COS showed GM loss, which did not progress during adolescence (unlike the progression seen in COS probands) and disappeared by age 20 years. The GM loss in siblings was most prominent in the prefrontal and temporal cortices as has been seen in COS probands, but un like that seen in probands, siblings did not show parietal GM loss at younger ages (except for a small region in the inferior parietal cortex). This GM loss in siblings of patients with COS appeared more prominent than that seen for the discordant dizygotic twin sample in the Cannon et al study,14 which also used fine GM density mapping, although comparisons across methods cannot be quantified. Furthermore, although the GM deficits in healthy siblings did not progress in a “back-to-front” pattern, seen in COS probands, visual comparison of the process of age-related amelioration of deficits did follow a somewhat similar pattern in both probands and siblings. This leads us to speculate that the younger age of our sibling group and lack of associated schizophrenia spectrum pathology may account for this plastic response (apparent inhibition of cortical thinning) in siblings as supported by the fact that within the healthy sibling group, cortical thickness increased with higher overall functioning as measured by the GAS.
Young, nonpsychotic siblings of patients with COS showed GM deficits mainly in the prefrontal and superior temporal cortices, regions with the most consistent cortical thickness deficits in adult subjects with schizophrenia5-7,56,57 and where GM deficits remain in COS probands as they become young adults.34 Prior studies in high-risk populations show cortical GM deficits12,19,58,59 that correlate with later development of psychosis,12,60,61 and unaffected first-degree relatives (including siblings and twins) also exhibit GM deficits.14,23,62-66 Fewer studies have focused specifically on siblings and report a modest smaller total GM volume (effect size, 0.18; 95% confidence interval, 0.01-0.35) but better agreement on decreased volume of the hippocampus or hippocampal-amygdalar complex.15,18,20,22,23,26,27,67 The findings for regional cortical GM deficits, however, remain inconsistent. For instance, as seen in some studies of unaffected relatives13 and our pilot study on healthy siblings,68 Cannon et al27 found frontal and temporal GM loss in siblings, while others have found no reduction in individual lobar GM volumes.25,26 Because the healthy siblings in this study show no phenotypic manifestations of the illness, GM abnormalities in the frontal and temporal regions are most likely to be familial/trait markers influenced by shared genetic factors. On the other hand, siblings showed minimal GM deficits in the parietal cortex, only at early ages and with little overlap with that seen for COS probands (Figure 1B), suggesting that GM loss for most of the parietal cortex (with the possible exception of the inferior parietal region) may be more under environmental- or illness-related influence. These findings are supported by the only comparable study, to our knowledge, of cortical mapping in discordant dizygotic twins with schizophrenia where prefrontal and polar cortices showed strong genetic liability while the parietal cortex appeared illness related.14
The degree of cortical normalization by age 20 years in siblings is surprising. Prior adult studies on high-risk populations and first-degree relatives show GM deficits well beyond age 20 years. There could be several reasons for this. In most adult sibling studies, brain abnormalities are most consistently seen in deeper cortical structures, which were not measured in the current study. The 2 prior adult sibling studies (both from the same group) that showed frontal and temporal GM deficits at later ages using either whole-lobe measures in siblings27 or cortical density maps in discordant twins14 (mean [SD] age, 40.7 [5.8] and 48.3 [2.9] years, respectively) included siblings with schizophrenia spectrum disorders in their analyses, which may have influenced their GM findings. Although subanalysis suggested this not to be the case in 127 of these 2 studies, our unpublished data suggest that the GM deficits in “spectrum siblings” (n = 12, 20 scans vs 40 controls with 61 scans) are more robust than those seen in healthy siblings and indeed appear to normalize at a later age (N.G. et al, unpublished data, 2007). Finally, in COS probands, the GM developmental trajectory appears to show a “shift to left” (deficits appearing in early ages, which improve by young adult age) compared with the adult subjects with schizophrenia with early parietal GM loss progressing during the adolescent years with relative improvement and localization to the adult pattern of frontal and temporal GM loss as subjects mature. It is possible that siblings of patients with COS may be showing a similar pattern of GM development as evidenced by early GM loss and early normalization. Thus, it may be possible that longer-term follow-up of high-functioning healthy adult siblings of patients with schizophrenia will ultimately show similar normalization of the deficits.
When cortical thickness was regressed with overall GAS scores, GM thickness increased with higher GAS scores, most prominently in bilateral prefrontal and temporal cortices (Figure 3). This direct relationship between normalization of cortical thickness and GAS scores would suggest that in the absence of core schizophrenia spectrum pathologic features or other confounding factors such as medication exposure, restitutive “normalization” of GM deficits (particularly in the prefrontal or temporal areas) in healthy siblings is closely related to their overall functioning. Better social and cognitive “competence” is associated with normalization (by inhibition of the regional GM loss). Whether this relationship between GM thickness and GAS score reflects cause or effect, or influence of yet another factor, remains unknown.
There are several limitations to this study. Many of our healthy siblings are not yet past the age of risk for schizophrenia (28 siblings were still younger than 20 years at last scan) and age at onset for Axis II disorders remains, for the most part, undetermined. However, the uniquely stringent definition of “healthy” in this group makes it unlikely that they will develop a psychotic or schizophrenia spectrum illness (mean [SD] age at last interview, 19.2 [7.6] years) and their GM deficit normalization may reflect this fact. Second, while all subjects had 2 scans, relatively few had 3 or more scans. Thus, although partially longitudinal, the group of siblings did not overlap with those at younger ages and the study remains susceptible to unknown cohort effects. Ongoing studies of new and extended follow-up of healthy siblings as well as siblings with schizophrenia spectrum diagnoses, which also include mapping of the deeper cortical structures, will continue to address some of these issues.
Correspondence: Nitin Gogtay, MD, Child Psychiatry Branch, National Institute of Mental Health, Bldg 10, Room 3N202, 10 Center Dr, MSC1600, Bethesda, MD 20892 (gogtayn@mail.nih.gov).
Submitted for Publication: August 7, 2006; final revision received December 14, 2006; accepted December 14, 2006.
Financial Disclosure: None reported.
1.Lawrie
SMAbukmeil
SS Brain abnormality in schizophrenia: a systematic and quantitative review of volumetric magnetic resonance imaging studies.
Br J Psychiatry 1998;172110- 120
PubMedGoogle ScholarCrossref 2.Wright
ICRabe-Hesketh
SWoodruff
PWDavid
ASMurray
RMBullmore
ET Meta-analysis of regional brain volumes in schizophrenia.
Am J Psychiatry 2000;157
(1)
16- 25
PubMedGoogle Scholar 4.Pantelis
CYucel
MWood
SJVelakoulis
DSun
DBerger
GStuart
GWYung
APhillips
LMcGorry
PD Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia.
Schizophr Bull 2005;31
(3)
672- 696
PubMedGoogle ScholarCrossref 5.Narr
KLBilder
RMToga
AWWoods
RPRex
DESzeszko
PRRobinson
DSevy
SGunduz-Bruce
HWang
YPDeLuca
HThompson
PM Mapping cortical thickness and gray matter concentration in first episode schizophrenia.
Cereb Cortex 2005;15
(6)
708- 719
PubMedGoogle ScholarCrossref 6.Kuperberg
GRBroome
MRMcGuire
PKDavid
ASEddy
MOzawa
FGoff
DWest
WCWilliams
SCvan der Kouwe
AJSalat
DHDale
AMFischl
B Regionally localized thinning of the cerebral cortex in schizophrenia.
Arch Gen Psychiatry 2003;60
(9)
878- 888
PubMedGoogle ScholarCrossref 7.Narr
KLToga
AWSzeszko
PThompson
PMWoods
RPRobinson
DSevy
SWang
YSchrock
KBilder
RM Cortical thinning in cingulate and occipital cortices in first episode schizophrenia.
Biol Psychiatry 2005;58
(1)
32- 40
PubMedGoogle ScholarCrossref 8.Gilbert
ARMontrose
DMSahni
SDDiwadkar
VAKeshavan
MS Obstetric complications correlate with neurobehavioral and brain structural alterations in young relatives at risk for schizophrenia.
Ann N Y Acad Sci 2003;1008269- 275
PubMedGoogle ScholarCrossref 9.Yücel
MWood
SJPhillips
LJStuart
GWSmith
DJYung
AVelakoulis
DMcGorry
PDPantelis
C Morphology of the anterior cingulate cortex in young men at ultra-high risk of developing a psychotic illness.
Br J Psychiatry 2003;182518- 524
PubMedGoogle ScholarCrossref 10.Cannon
TDvan Erp
TGBearden
CELoewy
RThompson
PToga
AWHuttunen
MOKeshavan
MSSeidman
LJTsuang
MT Early and late neurodevelopmental influences in the prodrome to schizophrenia: contributions of genes, environment, and their interactions.
Schizophr Bull 2003;29
(4)
653- 669
PubMedGoogle ScholarCrossref 11.Weinberger
DRMcClure
RK Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain?
Arch Gen Psychiatry 2002;59
(6)
553- 558
PubMedGoogle ScholarCrossref 12.Job
DEWhalley
HCJohnstone
ECLawrie
SM Grey matter changes over time in high risk subjects developing schizophrenia.
Neuroimage 2005;25
(4)
1023- 1030
PubMedGoogle ScholarCrossref 13.McIntosh
AMJob
DEMoorhead
WJHarrison
LKWhalley
HCJohnstone
ECLawrie
SM Genetic liability to schizophrenia or bipolar disorder and its relationship to brain structure.
Am J Med Genet B Neuropsychiatr Genet 2006;141
(1)
76- 83
PubMedGoogle ScholarCrossref 14.Cannon
TDThompson
PMvan Erp
TGToga
AWPoutanen
VPHuttunen
MLonnqvist
JStanderskjold-Nordenstam
CGNarr
KLKhaledy
MZoumalan
CIDail
RKaprio
J Cortex mapping reveals regionally specific patterns of genetic and disease-specific gray-matter deficits in twins discordant for schizophrenia.
Proc Natl Acad Sci U S A 2002;99
(5)
3228- 3233
PubMedGoogle ScholarCrossref 15.Cannon
TDvan Erp
TGRosso
IMHuttunen
MLonnqvist
JPirkola
TSalonen
OValanne
LPoutanen
VPStandertskjold-Nordenstam
CG Fetal hypoxia and structural brain abnormalities in schizophrenic patients, their siblings, and controls.
Arch Gen Psychiatry 2002;59
(1)
35- 41
PubMedGoogle ScholarCrossref 16.Hulshoff Pol
HEBrans
RGvan Haren
NESchnack
HGLangen
MBaare
WFvan Oel
CJKahn
RS Gray and white matter volume abnormalities in monozygotic and same-gender dizygotic twins discordant for schizophrenia.
Biol Psychiatry 2004;55
(2)
126- 130
PubMedGoogle ScholarCrossref 17.Narr
KLCannon
TDWoods
RPThompson
PMKim
SAsunction
Dvan Erp
TGPoutanen
VPHuttunen
MLonnqvist
JStanderksjold-Nordenstam
CGKaprio
JMazziotta
JCToga
AW Genetic contributions to altered callosal morphology in schizophrenia.
J Neurosci 2002;22
(9)
3720- 3729
PubMedGoogle Scholar 18.Staal
WGHulshoff Pol
HESchnack
Hvan der Schot
ACKahn
RS Partial volume decrease of the thalamus in relatives of patients with schizophrenia.
Am J Psychiatry 1998;155
(12)
1784- 1786
PubMedGoogle Scholar 19.Lawrie
SMWhalley
HCAbukmeil
SSKestelman
JNDonnelly
LMiller
PBest
JJOwens
DGJohnstone
EC Brain structure, genetic liability, and psychotic symptoms in subjects at high risk of developing schizophrenia.
Biol Psychiatry 2001;49
(10)
811- 823
PubMedGoogle ScholarCrossref 20.Van Erp
TGSaleh
PARosso
IMHuttunen
MLonnqvist
JPirkola
TSalonen
OValanne
LPoutanen
VPStandertskjold-Nordenstam
CGCannon
TD Contributions of genetic risk and fetal hypoxia to hippocampal volume in patients with schizophrenia or schizoaffective disorder, their unaffected siblings, and healthy unrelated volunteers.
Am J Psychiatry 2002;159
(9)
1514- 1520
PubMedGoogle ScholarCrossref 21.Keshavan
MSDick
EMankowski
IHarenski
KMontrose
DMDiwadkar
VDeBellis
M Decreased left amygdala and hippocampal volumes in young offspring at risk for schizophrenia.
Schizophr Res 2002;58
(2-3)
173- 183
PubMedGoogle ScholarCrossref 22.Seidman
LJFaraone
SVGoldstein
JMKremen
WSHorton
NJMakris
NToomey
RKennedy
DCaviness
VSTsuang
MT Left hippocampal volume as a vulnerability indicator for schizophrenia: a magnetic resonance imaging morphometric study of nonpsychotic first-degree relatives.
Arch Gen Psychiatry 2002;59
(9)
839- 849
PubMedGoogle ScholarCrossref 23.Boos
HBAleman
ACahn
WHulshoff Pol
HKahn
RS Brain volumes in relatives of patients with schizophrenia: a meta-analysis.
Arch Gen Psychiatry 2007;64
(3)
297- 304
PubMedGoogle ScholarCrossref 24.Marcelis
MSuckling
JWoodruff
PHofman
PBullmore
Evan Os
J Searching for a structural endophenotype in psychosis using computational morphometry.
Psychiatry Res 2003;122
(3)
153- 167
PubMedGoogle ScholarCrossref 25.McDonald
CMarshall
NSham
PCBullmore
ETSchulze
KChapple
BBramon
EFilbey
FQuraishi
SWalshe
MMurray
RM Regional brain morphometry in patients with schizophrenia or bipolar disorder and their unaffected relatives.
Am J Psychiatry 2006;163
(3)
478- 487
PubMedGoogle ScholarCrossref 26.Staal
WGHulshoff Pol
HESchnack
HGHoogendoorn
MLJellema
KKahn
RS Structural brain abnormalities in patients with schizophrenia and their healthy siblings.
Am J Psychiatry 2000;157
(3)
416- 421
PubMedGoogle ScholarCrossref 27.Cannon
TDvan Erp
TGHuttunen
MLonnqvist
JSalonen
OValanne
LPoutanen
VPStandertskjold-Nordenstam
CGGur
REYan
M Regional gray matter, white matter, and cerebrospinal fluid distributions in schizophrenic patients, their siblings, and controls.
Arch Gen Psychiatry 1998;55
(12)
1084- 1091
PubMedGoogle ScholarCrossref 28.Mathalon
DHSullivan
EVLim
KOPfefferbaum
A Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study.
Arch Gen Psychiatry 2001;58
(2)
148- 157
PubMedGoogle ScholarCrossref 29.Gur
RECowell
PTuretsky
BIGallacher
FCannon
TBilker
WGur
RC A follow-up magnetic resonance imaging study of schizophrenia: relationship of neuroanatomical changes to clinical and neurobehavioral measures.
Arch Gen Psychiatry 1998;55
(2)
145- 152
PubMedGoogle ScholarCrossref 30.Lieberman
JChakos
MWu
HAlvir
JHoffman
ERobinson
DBilder
R Longitudinal study of brain morphology in first episode schizophrenia.
Biol Psychiatry 2001;49
(6)
487- 499
PubMedGoogle ScholarCrossref 32.Thompson
PMMega
MSVidal
CRapoport
JToga
A Detecting Disease Specific Patterns of Brain Structure Using Cortical Pattern Matching and a Population-Based Probabilistic Brain Atlas, IEEE Conference on Information Processing in Medical Imaging (IPMI), UC Davis 2001. 2082 Berlin, Germany Springer-Verlag2001;
33.Rapoport
JLGiedd
JNBlumenthal
JHamburger
SJeffries
NFernandez
TNicolson
RBedwell
JLenane
MZijdenbos
APaus
TEvans
A Progressive cortical change during adolescence in childhood-onset schizophrenia: a longitudinal magnetic resonance imaging study.
Arch Gen Psychiatry 1999;56
(7)
649- 654
PubMedGoogle ScholarCrossref 34.Greenstein
DLerch
JShaw
PClasen
LGiedd
JGochman
PRapoport
JGogtay
N Childhood onset schizophrenia: cortical brain abnormalities as young adults.
J Child Psychol Psychiatry 2006;47
(10)
1003- 1012
PubMedGoogle ScholarCrossref 35.Gogtay
NGiedd
JNLusk
LHayashi
KMGreenstein
DVaituzis
ACNugent
TF
IIIHerman
DHClasen
LSToga
AWRapoport
JLThompson
PM Dynamic mapping of human cortical development during childhood through early adulthood.
Proc Natl Acad Sci U S A 2004;101
(21)
8174- 8179
PubMedGoogle ScholarCrossref 37.Sowell
ERPeterson
BSThompson
PMWelcome
SEHenkenius
ALToga
AW Mapping cortical change across the human life span.
Nat Neurosci 2003;6
(3)
309- 315
PubMedGoogle ScholarCrossref 38.Giedd
JNBlumenthal
JJeffries
NOCastellanos
FXLiu
HZijdenbos
APaus
TEvans
ACRapoport
JL Brain development during childhood and adolescence: a longitudinal MRI study.
Nat Neurosci 1999;2
(10)
861- 863
PubMedGoogle ScholarCrossref 39.McKenna
KGordon
CTLenane
MKaysen
DFahey
KRapoport
JL Looking for childhood-onset schizophrenia: the first 71 cases screened.
J Am Acad Child Adolesc Psychiatry 1994;33
(5)
636- 644
PubMedGoogle ScholarCrossref 40.Kumra
SFrazier
JAJacobsen
LKMcKenna
KGordon
CTLenane
MCHamburger
SDSmith
AKAlbus
KEAlaghband-Rad
JRapoport
JL Childhood-onset schizophrenia: a double-blind clozapine-haloperidol comparison.
Arch Gen Psychiatry 1996;53
(12)
1090- 1097
PubMedGoogle ScholarCrossref 41.Endicott
JSpitzer
RL Schedule for Affective Disorders and Schizophrenia (SADS) [in French].
Acta Psychiatr Belg 1987;87
(4)
361- 516
PubMedGoogle Scholar 42.Kaufman
JBirmaher
BBrent
DRao
UFlynn
CMoreci
PWilliamson
DRyan
N Schedule for Affective Disorders and Schizophrenia for School-Age Children–Present and Lifetime Version (K-SADS-PL): initial reliability and validity data.
J Am Acad Child Adolesc Psychiatry 1997;36
(7)
980- 988
PubMedGoogle ScholarCrossref 43.Stangl
DPfohl
BZimmerman
MBowers
WCorenthal
C A structured interview for the
DSM-III personality disorders: a preliminary report.
Arch Gen Psychiatry 1985;42
(6)
591- 596
PubMedGoogle ScholarCrossref 44.Shaffer
DGould
MSBrasic
JAmbrosini
PFisher
PBird
HAluwahlia
S A children's global assessment scale (CGAS).
Arch Gen Psychiatry 1983;40
(11)
1228- 1231
PubMedGoogle ScholarCrossref 45.Asarnow
RFNuechterlein
KHFogelson
DSubotnik
KLPayne
DARussell
ATAsamen
JKuppinger
HKendler
KS Schizophrenia and schizophrenia-spectrum personality disorders in the first-degree relatives of children with schizophrenia: the UCLA family study.
Arch Gen Psychiatry 2001;58
(6)
581- 588
PubMedGoogle ScholarCrossref 46.Castellanos
FXGiedd
JNBerquin
PCWalter
JMSharp
WTran
TVaituzis
ACBlumenthal
JDNelson
JBastain
TMZijdenbos
AEvans
ACRapoport
JL Quantitative brain magnetic resonance imaging in girls with attention-deficit/hyperactivity disorder.
Arch Gen Psychiatry 2001;58
(3)
289- 295
PubMedGoogle ScholarCrossref 47.Sled
JGZijdenbos
APEvans
AC A nonparametric method for automatic correction of intensity nonuniformity in MRI data.
IEEE Trans Med Imaging 1998;17
(1)
87- 97
PubMedGoogle ScholarCrossref 48.Zijdenbos
APForghani
REvans
AC Automatic “pipeline” analysis of 3-D MRI data for clinical trials: application to multiple sclerosis.
IEEE Trans Med Imaging 2002;21
(10)
1280- 1291
PubMedGoogle ScholarCrossref 49.Kim
JSSingh
VLee
JKLerch
JAd-Dab'bagh
YMacDonald
DLee
JMKim
SIEvans
AC Automated 3-D extraction and evaluation of the inner and outer cortical surfaces using a Laplacian map and partial volume effect classification.
Neuroimage 2005;27
(1)
210- 221
PubMedGoogle ScholarCrossref 50.MacDonald
DKabani
NAvis
DEvans
AC Automated 3-D extraction of inner and outer surfaces of cerebral cortex from MRI.
Neuroimage 2000;12
(3)
340- 356
PubMedGoogle ScholarCrossref 51.Robbins
SEvans
ACCollins
DLWhitesides
S Tuning and comparing spatial normalization methods.
Med Image Anal 2004;8
(3)
311- 323
PubMedGoogle ScholarCrossref 52.Lerch
JPEvans
AC Cortical thickness analysis examined through power analysis and a population simulation.
Neuroimage 2005;24
(1)
163- 173
PubMedGoogle ScholarCrossref 53.Diggle
PLiang
KZeger
S Analysis of Longitudinal Data. Oxford, England Oxford University Press 1994;
54.Genovese
CRLazar
NANichols
T Thresholding of statistical maps in functional neuroimaging using the false discovery rate.
Neuroimage 2002;15
(4)
870- 878
PubMedGoogle ScholarCrossref 55.Hollingshead
ABed Four Factor Index for Social Status. New Haven, CT Yale University 1975;
56.Wiegand
LCWarfield
SKLevitt
JJHirayasu
YSalisbury
DFHeckers
SDickey
CCKikinis
RJolesz
FAMcCarley
RWShenton
ME Prefrontal cortical thickness in first-episode psychosis: a magnetic resonance imaging study.
Biol Psychiatry 2004;55
(2)
131- 140
PubMedGoogle ScholarCrossref 57.White
TAndreasen
NCNopoulos
PMagnotta
V Gyrification abnormalities in childhood- and adolescent-onset schizophrenia.
Biol Psychiatry 2003;54
(4)
418- 426
PubMedGoogle ScholarCrossref 58.Job
DEWhalley
HCMcConnell
SGlabus
MJohnstone
ECLawrie
SM Voxel-based morphometry of grey matter densities in subjects at high risk of schizophrenia.
Schizophr Res 2003;64
(1)
1- 13
PubMedGoogle ScholarCrossref 59.Lymer
GKJob
DEWilliam
TMoorhead
JMcIntosh
AMOwens
DGJohnstone
ECLawrie
SM Brain-behaviour relationships in people at high genetic risk of schizophrenia.
Neuroimage 2006;33
(1)
275- 285
PubMedGoogle ScholarCrossref 60.Lawrie
SMWhalley
HCAbukmeil
SSKestelman
JNMiller
PBest
JJOwens
DGJohnstone
EC Temporal lobe volume changes in people at high risk of schizophrenia with psychotic symptoms.
Br J Psychiatry 2002;181138- 143
PubMedGoogle Scholar 61.Pantelis
CVelakoulis
DMcGorry
PDWood
SJSuckling
JPhillips
LJYung
ARBullmore
ETBrewer
WSoulsby
BDesmond
PMcGuire
PK Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison.
Lancet 2003;361
(9354)
281- 288
PubMedGoogle ScholarCrossref 62.Suddath
RLChristison
GWTorrey
EFCasanova
MFWeinberger
DR Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia.
N Engl J Med 1990;322
(12)
789- 794
PubMedGoogle ScholarCrossref 63.Baaré
WFCvan Oel
CJHulshoff Pol
HESchnack
HGDurston
SSitskoorn
MMKahn
RS Volumes of brain structures in twins discordant for schizophrenia.
Arch Gen Psychiatry 2001;58
(1)
33- 40
PubMedGoogle ScholarCrossref 64.Schulze
KMcDonald
CFrangou
SSham
PGrech
AToulopoulou
TWalshe
MSharma
TSigmundsson
TTaylor
MMurray
RM Hippocampal volume in familial and nonfamilial schizophrenic probands and their unaffected relatives.
Biol Psychiatry 2003;53
(7)
562- 570
PubMedGoogle ScholarCrossref 65.McNeil
TFCantor-Graae
EWeinberger
DR Relationship of obstetric complications and differences in size of brain structures in monozygotic twin pairs discordant for schizophrenia.
Am J Psychiatry 2000;157
(2)
203- 212
PubMedGoogle ScholarCrossref 66.McDonald
CGrech
AToulopoulou
TSchulze
KChapple
BSham
PWalshe
MSharma
TSigmundsson
TChitnis
XMurray
RM Brain volumes in familial and non-familial schizophrenic probands and their unaffected relatives.
Am J Med Genet 2002;114
(6)
616- 625
PubMedGoogle ScholarCrossref 67.Seidman
LJFaraone
SVGoldstein
JMGoodman
JMKremen
WSMatsuda
GHoge
EAKennedy
DMakris
NCaviness
VSTsuang
MT Reduced subcortical brain volumes in nonpsychotic siblings of schizophrenic patients: a pilot magnetic resonance imaging study.
Am J Med Genet 1997;74
(5)
507- 514
PubMedGoogle ScholarCrossref 68.Gogtay
NSporn
AClasen
LSGreenstein
DGiedd
JNLenane
MGochman
PAZijdenbos
ARapoport
JL Structural brain MRI abnormalities in healthy siblings of patients with childhood-onset schizophrenia.
Am J Psychiatry 2003;160
(3)
569- 571
PubMedGoogle ScholarCrossref